• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VENOUS WALLSTENT; STENT, ILIAC VEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VENOUS WALLSTENT; STENT, ILIAC VEIN Back to Search Results
Model Number H74912044166070
Device Problem Migration (4003)
Patient Problems Atrial Fibrillation (1729); Unspecified Heart Problem (4454)
Event Date 09/15/2022
Event Type  Injury  
Event Description
It was reported that the stents migrated and required explant.On (b)(6) 2020, a 16x60 venous wallstent was implanted in the external iliac vein.The patient presented with right common iliac and external iliac vein compression.Ivus imaging was obtained along with measurements, and a pre-dilation of the common iliac and external iliac was performed with a 14x60 and a 16x60 xxl balloon.An additional ivus run was recorded, and it was noted that there was recoil.The decision was made to place a 14x60 vici stent in the right common iliac vein.There was still compression in the external iliac vein, so an additional stent (16x60 venous wallstent) was placed in the external iliac vein.Post dilation of the stents was performed.A follow up intravascular ultrasound exam revealed significant improvement with an increase in cross-sectional area.A venogram was also performed, and the physician completed the procedure.Patient tolerated the procedure well and recovered with no complications.6-month follow ups were performed with ultrasound, and the stents were intact.Sometime in the two weeks prior to (b)(6) 2022, the patient presented with heart palpitations.Both the vici and venous wallstent had migrated to the right atrium (ra).The patient was referred for endovascular stent retrieval.Both stents were removed from the ra using forceps via femoral vein access on (b)(6) 2022.The patient tolerated the procedure and is expected to make a full recovery.
 
Manufacturer Narrative
Date of event estimated using date of stent explantation.
 
Event Description
It was reported that the stents migrated and required explant.On (b)(6) 2020, a 16x60 venous wallstent was implanted in the external iliac vein.The patient presented with right common iliac and external iliac vein compression.Ivus imaging was obtained along with measurements, and a pre-dilation of the common iliac and external iliac was performed with a 14x60 and a 16x60 xxl balloon.An additional ivus run was recorded, and it was noted that there was recoil.The decision was made to place a 14x60 vici stent in the right common iliac vein.There was still compression in the external iliac vein, so an additional stent (16x60 venous wallstent) was placed in the external iliac vein.Post dilation of the stents was performed.A follow up intravascular ultrasound exam revealed significant improvement with an increase in cross-sectional area.A venogram was also performed, and the physician completed the procedure.Patient tolerated the procedure well and recovered with no complications.6-month follow ups were performed with ultrasound, and the stents were intact.Sometime in the two weeks prior to (b)(6) 2022, the patient presented with heart palpitations.Both the vici and venous wallstent had migrated to the right atrium (ra).The patient was referred for endovascular stent retrieval.Both stents were removed from the ra using forceps via femoral vein access on (b)(6) 2022.The patient tolerated the procedure and is expected to make a full recovery.It was further reported that the patient went to the hospital on (b)(6) 2022 for atrial fibrillation and was discharged on (b)(6) 2022.The stents were not discovered during this time.On (b)(6) 2022, there was a consult for removal of stents in the ivc/ra.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENOUS WALLSTENT
Type of Device
STENT, ILIAC VEIN
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15720974
MDR Text Key303040851
Report Number2124215-2022-43824
Device Sequence Number1
Product Code QAN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P980033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/16/2022
Device Model NumberH74912044166070
Device Catalogue NumberH74912044166070
Device Lot Number0026023257
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/30/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/16/2020
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient SexMale
Patient Weight118 KG
-
-